Clinical trial assessing penile prosthesis implant recovery care

This study evaluates the concept of ERIC (Enhanced Recovery Implant Care) on clinical outcomes and patient satisfaction rates following inflatable penile prosthesis (IPP) surgery. The concept of ERIC includes strict intraoperative and postoperative care to maximise patient comfort and minimise surgical bruising (strict perioperative analgesic regime of intra-operative nerve block and device drug elution use, meticulous haemostatic closure and fitted scrotal care following IPP surgery). Professor Eric Chung is the principal supervisor/investigator for this trial. The setting for this trial is undertaken at various hospitals (Princess Alexandra Hospital, Greenslopes Private Hospital and St Andrew's War Memorial Hospital) with the involvement of the AndroUrology Centre. The intervention was performed over 12 months. Monitoring of intervention was carried out by an independent third party. Perioperative analgesia regime consists of the following combination of oral medications - Oxycodone 5mg four times a day as required, tapentadol 100mg four times a day as required and NSAID (ibuprofen 400mg twice daily) for 7 days postoperatively. All patients complete a drug chart to document the intake of analgesia. Meticulous hemostasis consists of water-tight closure of corporotomies, use of Surgicel fibrillar hemostat and 2-layer dartos closure of the scrotum. The perioperative regime is administered by a nurse on day 0 of surgery and patients will take the necessary analgesia once discharged from the hospital.